Showing results (41-50 of 2,396) with videos related to

Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|March 23, 2016
Advances in personalized cancer immunotherapyKazuhiro Kakimi, Takahiro Karasaki, Hirokazu Matsushita, et al.
Breast Cancer (Tokyo, Japan)|July 20, 2017
CircRNA: a novel type of biomarker for cancerHe-da Zhang, Lin-Hong Jiang, Da-Wei Sun, et al.
Breast Cancer (Tokyo, Japan)|June 18, 2016
Ductal carcinoma in situ and ductal carcinoma in situ with microinvasion: correlation of FDG uptake with histological and biological prognostic factorsYe Young Seo, Ie Ryung Yoo, Sonya Youngju Park, et al.
Breast Cancer (Tokyo, Japan)|September 1, 2017
Inter-observer agreement among pathologists in grading the pathological response to neoadjuvant chemotherapy in breast cancerTakeshi Yamaguchi, Hirofumi Mukai, Futoshi Akiyama, et al.
Breast Cancer (Tokyo, Japan)|March 28, 2016
Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group comparative studyJunichi Kurebayashi, Tatsuya Toyama, Shuuji Sumino, et al.
Breast Cancer (Tokyo, Japan)|April 21, 2016
A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicityKouloulias Vassilis, Gogalis Ioannis, Zygogianni Anna, et al.
Breast Cancer (Tokyo, Japan)|December 15, 2015
A very rare case of breast cancer in a female-to-male transsexualYuko Katayama, Takayuki Motoki, Satoko Watanabe, et al.
Breast Cancer (Tokyo, Japan)|December 15, 2015
Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort studyCamilla Praestegaard, Susanne K Kjaer, Michael Andersson, et al.
Breast Cancer (Tokyo, Japan)|February 15, 2016
Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancerKatsuhiko Nakatsukasa, Hiroshi Koyama, Yoshimi Oouchi, et al.
Breast Cancer (Tokyo, Japan)|July 26, 2022
Neurospora crassa is a potential source of anti-cancer agents against breast cancerRui Han, Hongxing Yang, Changquan Ling, et al.
Pageof 240